Catalyst Biosciences Inc buy Jefferies Financial Group Inc.
Start price
25.08.25
/
50%
€0.52
Target price
25.08.26
€22.23
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 25.08.26. The prediction end date can be changed by Jefferies_Financial_ at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Catalyst Biosciences Inc | - | - |
| iShares Core DAX® | -1.764% | 2.259% |
| iShares Nasdaq 100 | -1.632% | -0.193% |
| iShares Nikkei 225® | -2.451% | 4.086% |
| iShares S&P 500 | -2.252% | -0.151% |
Comments by Jefferies_Financial_ for this prediction
In the thread Catalyst Biosciences Inc diskutieren
Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $26.00 price target on the stock.
Ratings data for CBIO provided by MarketBeat